Citius Pharmaceuticals (CTXR) Liabilities and Shareholders Equity (2011 - 2026)
Citius Pharmaceuticals (CTXR) reported Liabilities and Shareholders Equity of $142.26 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 11.4% from $127.68 million a year earlier and up 7.3% from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals posted Liabilities and Shareholders Equity of $130.94 million, up 12.2% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 24.5% (FY2020 to FY2025).
- By fiscal year, Liabilities and Shareholders Equity came in at $116.65 million in FY2024 (+12.6%), $103.61 million in FY2023 (-9.1%), $114 million in FY2022 (-20.0%) and $142.43 million in FY2021 (+225.4%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity since fiscal Q4 2021.
- Year over year, Liabilities and Shareholders Equity has now increased in each of the last eight quarters, with growth averaging 18.9% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was fiscal Q1 2022 (growth of 289.4%); the low point was fiscal Q4 2022 (a decline of 20.0%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $132.54 million (Q2 2026), $140.39 million (Q1 2026) and $130.94 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Citius Pharmaceuticals | 10.37 Mn | -23.20 Mn | 1.00 Mn | 142.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.26 Mn |
| Mar 31, 2026 | 132.54 Mn |
| Dec 31, 2025 | 140.39 Mn |
| Sep 30, 2025 | 130.94 Mn |
| Jun 30, 2025 | 127.68 Mn |
| Mar 31, 2025 | 121.48 Mn |
| Dec 31, 2024 | 120.70 Mn |
| Sep 30, 2024 | 116.65 Mn |
| Jun 30, 2024 | 97.09 Mn |
| Mar 31, 2024 | 90.71 Mn |
| Dec 31, 2023 | 97.40 Mn |
| Sep 30, 2023 | 103.61 Mn |
| Jun 30, 2023 | 110.40 Mn |
| Mar 31, 2023 | 104.24 Mn |
| Dec 31, 2022 | 111.71 Mn |
| Sep 30, 2022 | 114.00 Mn |
| Jun 30, 2022 | 120.32 Mn |
| Mar 31, 2022 | 127.79 Mn |
| Dec 31, 2021 | 137.52 Mn |
| Sep 30, 2021 | 142.43 Mn |
API Access
Citius Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();